ArticleDiabetologia2019
CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor.
Philippe P Pagni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it